6-Chloro-1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridine

Catalog No. :
ACLGOP312
CAS No. :
896722-50-2
Molecular Formula :
C13H9ClN2O2S
Molecular Weight :
292.75

IUPAC Name:6-chloro-1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridine

6-Chloro-1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$117.00Login to see priceIn stockInquiry
5g95%$409.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name6-Chloro-1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridine
IUPAC Name6-chloro-1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridine
MDL No.MFCD11616448
Molecular FormulaC13H9ClN2O2S
Molecular Weight292.75
SMILESClC1=CC=C2C=CN(C2=N1)S(=O)(=O)C1=CC=CC=C1
InChI KeyMLCIWUYAGVFRMD-UHFFFAOYSA-N
SynonymAKOS016005247 | 1-(phenylsulphonyl)-6-chloro-7-azaindole | 1-(Benzenesulfonyl)-6-chloro-1H-pyrrolo[2,3-b]pyridine | SB14044 | 6-Chloro-1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridine | CS-0004201 | DTXSID80677996 | 1H-Pyrrolo[2,3-b]pyridine,6-chloro-1-(pheny
CAS No.896722-50-2
PubChem CID49759033

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACLGOP312 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACWJCT705 route compound structure diagram
    ACWJCT70555052-27-2 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLGOP312 route product structure diagram
    ACLGOP312896722-50-2 In Stock
Inquiry

2. ACLGOP312 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLGOP312 route product structure diagram
    ACLGOP312896722-50-2 In Stock
Inquiry

Comments (0)